Detailed Narrative
Strong Sequential Performance Despite Market Headwinds
Aarti Industries reported robust sequential growth in Q2 FY26, with revenue increasing by 21% Q-o-Q to ₹2,250 crores. This was primarily driven by improved volumes across key product categories. EBITDA saw an even stronger surge of 36% Q-o-Q to ₹292 crores, benefiting from enhanced capacity utilization and ongoing cost optimization initiatives. Consequently, Profit After Tax (PAT) jumped by approximately 150% Q-o-Q to ₹106 crores, reflecting improved operating leverage.
Strategic Response to US Tariffs and Market Diversification
The company acknowledged US tariffs on Indian chemical exports as a near-term headwind, impacting competitiveness. In response, Aarti Industries has actively diversified its export mix towards Europe, the Middle East, and Africa, while recalibrating its US strategy. Management noted that while Q2 FY26 saw pain from US tariffs, this was offset by growth in other geographies. They anticipate policy clarity and normalization of trade flows in the medium term, with a potential India-US trade deal acting as a significant catalyst.
Capacity Expansion and Project Commissioning Pipeline
Aarti Industries is progressing with its Zone 4 expansion project. A Calcium Chloride facility is expected to be commissioned in the current quarter (Q2 FY26), followed by a new Multipurpose Plant (MPP) in Q4 FY26. Additionally, a 4,000 TPA PEDA project in Jhagadia, utilizing raw materials from existing Ethylation capacity, is set for commissioning in Q3 FY26. Further MMA debottlenecking and 5 incremental chemistry-oriented blocks in Zone 4 are planned for sequential commissioning throughout FY27, enhancing product flexibility and integration.
Cost Optimization and Margin Outlook
The company has implemented cost optimization initiatives targeting ₹150-200 crores in benefits. Management indicated that roughly 40-50% of these benefits are yet to flow through to the bottom line, with a significant portion expected in FY27, particularly from renewable power purchase agreements. While raw material and product pricing volatility remains high, sustained volumes are expected to drive operating leverage and support margin expansion.
Product Segment Performance and Future Mix
MMA delivered its highest-ever quarterly volumes, driven by spill-over demand from Q1 and diversification efforts. The energy segment's contribution is expected to stabilize at 30-40% in the steady state after Zone 4 capacity comes online, with agro, polymer, and pharma segments gradually increasing their share. The DCB segment, though negative year-on-year, showed quarter-on-quarter recovery from a weak Q1, with a revised strategy aiming for a strong second half.
Capital Expenditure and Debt Strategy
Capex for Q2 FY26 was ₹267 crores, with the full-year FY26 guidance maintained at around ₹1,000 crores. For FY27, capex is projected to be substantially lower than ₹1,000 crores. The company's capital allocation strategy is shifting towards medium-ticket projects that offer quick turnaround and significant returns, leveraging existing infrastructure. Management believes the debt-to-EBITDA ratio may have already peaked, indicating a focus on improving leverage going forward⏳.